| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 4,200 | ₹2.35 0% | 1,4000% |
| 1,20033.33% | ₹588.3 6.39% | 4,300 | - | - |
| 00% | ₹469.3 0% | 4,400 | ₹8.9 -19.09% | 5,100112.5% |
| - | - | 4,450 | ₹15 0% | 1000% |
| 900350% | ₹370.1 -11.67% | 4,500 | ₹15.7 -13.97% | 34,90014.42% |
| 2000% | ₹310.35 0% | 4,600 | ₹25.7 -16.69% | 72,50010.18% |
| - | - | 4,650 | ₹34.4 -14.85% | 4,70062.06% |
| 1,20020% | ₹232 9.9% | 4,700 | ₹40.65 -20.05% | 39,2000% |
| 1000% | ₹190.75 0% | 4,750 | ₹52.45 -20.34% | 6,600-14.28% |
| 14,30032.40% | ₹154.9 -0.38% | 4,800 | ₹70.65 -15.33% | 68,50016.49% |
| 14,60056.98% | ₹122.9 -3.72% | 4,850 | ₹90.9 -14.32% | 24,70016.50% |
| 51,70012.63% | ₹99 -3.27% | 4,900 | ₹116.2 -11.19% | 39,2000.25% |
| 19,50022.64% | ₹77.95 -4.93% | 4,950 | ₹146.75 -9.46% | 12,300-3.14% |
| 1,21,50015.82% | ₹61 -7.78% | 5,000 | ₹179 -7.94% | 1,05,100-0.47% |
| 18,8001.62% | ₹48.3 -7.91% | 5,050 | ₹216.05 -7.19% | 9,800-2.97% |
| 84,2002.80% | ₹37.75 -11.17% | 5,100 | ₹256 -4.85% | 21,800-3.11% |
| 19,80015.78% | ₹29.1 -13.52% | 5,150 | ₹302.4 -8.61% | 1,9005.55% |
| 86,500-3.35% | ₹24.55 -10.72% | 5,200 | ₹361.25 3.37% | 20,400-1.44% |
| 25,7000.39% | ₹19.35 -10.2% | 5,250 | ₹407.45 0% | 11,6000% |
| 97,0009.85% | ₹15.15 -12.93% | 5,300 | ₹418.55 0% | 9,2000% |
| 24,3009.95% | ₹11.2 -23.54% | 5,350 | - | - |
| 79,9001.52% | ₹10.1 -13.3% | 5,400 | ₹481.7 0% | 5,8000% |
| 13,200-2.22% | ₹8.9 -18.34% | 5,450 | ₹571 9.01% | 1000% |
| 50,10011.08% | ₹7 -16.66% | 5,500 | ₹515 0% | 2000% |
| 3,300-8.33% | ₹5.25 -21.64% | 5,550 | - | - |
| 73,2006.39% | ₹6.05 -19.33% | 5,600 | ₹700 0% | 1000% |
| 6000% | ₹15.7 0% | 5,650 | - | - |
| 7,9005.33% | ₹4 -20% | 5,700 | - | - |
| 1000% | ₹3.25 0% | 5,750 | - | - |
| 1,800-10% | ₹2.35 -49.46% | 5,800 | ₹530 0% | 1000% |
| 2,0001900% | ₹1.9 -22.44% | 5,900 | - | - |
| 6,100-8.95% | ₹1.1 -45% | 6,000 | - | - |
| 3,50034.61% | ₹2.8 107.4% | 6,100 | ₹850 0% | 2000% |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
